bispecific antibody therapy

Beerse, Belgium — March 10, 2026 Global healthcare company Johnson & Johnson has announced the submission of a Type...

CAMBRIDGE, Massachusetts, USA & COPENHAGEN, Denmark — March 5, 2026 Hemab Therapeutics, a clinical-stage biotechnology company focused on developing...

PLYMOUTH MEETING, Pennsylvania & HONG KONG, March 4, 2026 INOVIO Pharmaceuticals and Akeso Inc. have announced a strategic clinical...